About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 82 record(s)
Req # A-2023-00029
The minutes of the CNSC’s Management Committee for May 2023.Organization: Canadian Nuclear Safety Commission
July 2023
Req # A-2023-000312
The National Microbiology Laboratory‘s report on BTNX‘s 200 samples.Organization: Health Canada
July 2023
Req # A-2023-000341
2022 and 2023 Annual Report to the Head of Compliance and Enforcement as required under section 36 of the Work Place Harassment and Violence Prevention Regulations.Organization: Health Canada
July 2023
Req # A-2023-000449
The number of adverse reaction reports received by Health Canada for a neuroleptic drug from April 1, 2020 to March 31, 2023.Organization: Health Canada
July 2023
Req # A-2020-001753
Adverse Drug Reaction (ADR). Report number: E2B_03462673.Organization: Health Canada
July 2023
Req # A-2022-001099
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108621-44, Breast Implant Registry Considerations - Update.Organization: Health Canada
July 2023
Req # A-2023-000161
Adverse Drug Reactions (ADRs) for TEMODAL. Report numbers: E2B_03072550, E2B_02069473, E2B_02600423, E2B_02839770, E2B_03200196.Organization: Health Canada
July 2023
Req # A-2022-00033
ITEM 1 Tiger Team report produced by the Strategic Communication's Directorate in late 2019 on how the directorate was to manage and improve work as a result of the poor 2019 Public Service Employee Survey results that was presented to SCD management. Tiger Team members included: Shawn Murphy, Dominique Morrissette, Alexandra Szabo, Héloïse Perron, Sophie Dagenais, Rhonda Walker-Sisttie This would include: The document produced from the Tiger Team members Discussions/correspondence around the document Results/follow-up on the recommendations provided Source: eDocs and emails ITEM 2 Strategic Communications Directorate Emergency Process document Specifically responsibilities during emergencies and process documents Source: eDocs ITEM 3 List of all documents produced by Gérard Dicks Pellerin in eDocs List should include the following information: eDoc number Document name Date created Source: extraction from eDocOrganization: Canadian Nuclear Safety Commission
July 2022
Req # A-2022-00048
The minutes of the CNSC’s Management Committee fo June 2022.Organization: Canadian Nuclear Safety Commission
July 2022
Req # A-2017-001792
The most recent Drug Establishment Licence for Auro Pharma including any annexes listing foreign buildings and the drugs they are licensed to produce.Organization: Health Canada
July 2022